Dr. Sherief M. Kamel, MD

Dr. Kamel practices at Institute of Endocrinology Diabetes Health and Hormones in Destin, Florida.

Dr. Kamel's NPI, 1265474563, was assigned on June 12, 2006. Dr. Kamel graduated from University of Alexandria Faculty of Medicine in 1994. Dr. Kamel holds Florida license ME92200.

Dr. Kamel's primary practice is Institute of Endocrinology Diabetes Health and Hormones, at 1241 Airport Rd, Destin, FL 32541 in Okaloosa County. The practice phone is (850) 522-5490.

Dr. Kamel's primary practice is Institute of Endocrinology Diabetes Health and Hormones in Destin, Florida. Dr. Kamel is also affiliated with HCA Florida Gulf Coast Hospital. The medical group on file is Institute of Endocrinology Diabetes, Health & Hormones. Dmand AI also links Dr. Kamel to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamel practices, 3 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Kamel's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Kamel is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Kamel's licenses on file in 4 states: Florida, Georgia, Texas and Tennessee.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol, hypercalcemia, obesity and osteoporosis among the conditions Dr. Kamel treats.

CMS data shows 8,114 Medicare services from Dr. Kamel across 22 procedure codes in 2024, for 1,245 Medicare patients. Medicare paid $281,606 for them.

CMS counts 1,245 Medicare patients who saw Dr. Kamel in 2024. The largest group is 65 to 74, with 623 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kamel's median patient age at 58, with 70% women.

In 2024, Dr. Kamel wrote 2,521 Medicare Part D claims for 577 patients. 54% of them were for generic drugs. CMS names the drug for 1,963 of them, across 55 drugs with 11 or more claims each, at $724,460 in total drug cost. In 2023, CMS named 4,525 claims across 91 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kamel for performance year 2024, reported individually. Dr. Kamel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 582 general payments to Dr. Kamel from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $38,846.

Dmand AI lists 1 award for Dr. Kamel.

Dr. Kamel graduated from University of Alexandria Faculty of Medicine in 1994.

Dr. Kamel is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.